Stay updated on METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Sign up to get notified when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.

Latest updates to the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page
- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner announces an NIH website transition and explains that both “Super Intelligence” and “Artificial Intelligence” terminology may appear during the change.SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2 while the page remains a 403 error page.SummaryDifference0.2%

- Check28 days agoChange DetectedThe 403 Forbidden page’s footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedA 403 Forbidden page appears where the Study Details used to be, hiding the study information and documents. The previous content and navigation related to the study are no longer visible.SummaryDifference21%

- Check70 days agoChange DetectedA funding note '2017 ( U.S. NIH Grant/Contract )' was added to the study's identifiers and the site revision was updated to v3.6.6 (replacing v3.6.5).SummaryDifference0.1%

Stay in the know with updates to METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Enter your email address, and we'll notify you when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.